Skip to main content
Premium Trial:

Request an Annual Quote

EU Therapeutics Program Hires Biobase to Help Develop Target ID Methods

NEW YORK (GenomeWeb News) — A group of European research institutes has hired Biobase to help it develop informatics tools and experimental methods for identifying therapeutic targets, the company said today.
 
Biobase said it will help develop bioinformatics and cheminformatics for the European Union-commissioned Net2Drug project, which is a consortium of institutes from Europe and Russia that represents interdisciplinary fields including toxicology, systems biology, pharmacology, and cancer.
 
The project “will integrate different omics datasets such as proteomics and genomics into cohesive networks” to help study diseases.
 
Any resulting methods or technologies will be tested on “certain tumor types,” particularly on breast cancer, said Alexander Kel, Biobase senior vice president of R&D.
 
Net2Drug is part of the EU’s Sixth Framework program, which was funded with $2.5 billion between 2002 and 2006, and which sets aside as much as $475 million for cancer research.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.